Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	98433
Country	China

Received	2024-08-19 08:05
Peer-Review Started	2024-06-26 03:45
To Make the First Decision
Return for Revision	2024-09-27 15:27
Revised	2024-10-10 14:11
Second Decision	2024-11-04 02:40
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-11-04 07:51
Articles in Press	2024-11-04 07:51
Publication Fee Transferred	2024-11-06 12:56
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-11-14 15:36
Publish the Manuscript Online	2024-12-12 09:30

ISSN	1948-5204 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Case Report
Article Title	Complete response of gallbladder cancer treated with gemcitabine and cisplatin chemotherapy combined with durvalumab: A case report and review of literature
Manuscript Source	Unsolicited Manuscript
All Author List	Kai Chen, Xu Feng, Yuan Shi, Xin-Lin Li, Zheng-Rong Shi and Xiang Lan
ORCID	Author(s) ORCID Number Kai Chen http://orcid.org/0000-0003-1083-073X Xu Feng http://orcid.org/0000-0003-4579-8557 Zheng-Rong Shi http://orcid.org/0000-0003-4950-3613 Xiang Lan http://orcid.org/0000-0002-5626-0106
Funding Agency and Grant Number	Funding Agency Grant Number General Project of Natural Science Foundation of Chongqing, China cstc2021jcyj-msxmX0604 Chongqing Doctoral "Through Train" Research Program, China CSTB2022BSXM-JCX0045
Corresponding Author	Xiang Lan, PhD, Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Youyi Road, Yuzhong District, Chongqing 400016, China. lanxiang_tmmu@163.com
Key Words	Gallbladder cancer; Chemotherapy; Immunotherapy; Durvalumab; Complete response; Case report
Core Tip	This study presents a significant case of a patient with locally advanced gallbladder cancer (GBC) who achieved a clinical complete response following treatment with a novel regimen combining gemcitabine, cisplatin, and durvalumab (GC-D). Despite the notorious resistance of GBC to conventional therapies, the positive outcomes observed in this case suggest potential benefits of immunotherapy in this context. These findings highlight the need for further research to validate the efficacy of the GC-D regimen and to explore its implications for future treatment protocols in GBC.
Publish Date	2024-12-12 09:30
Citation	<p>Chen K, Feng X, Shi Y, Li XL, Shi ZR, Lan X. Complete response of gallbladder cancer treated with gemcitabine and cisplatin chemotherapy combined with durvalumab: A case report and review of literature. <i>World J Gastrointest Oncol</i> 2025; 17(1): 98433</p>
URL	https://www.wjgnet.com/1948-5204/full/v17/i1/98433.htm
DOI	https://dx.doi.org/10.4251/wjgo.v17.i1.98433

Full Article (PDF)	WJGO-17-98433-with-cover.pdf
CARE Checklist–2016	98433-CARE-Checklist-2016.pdf
Manuscript File	98433_Auto_Edited_062824.docx
Answering Reviewers	98433-answering-reviewers.pdf
Audio Core Tip	98433-audio.mp3
Conflict-of-Interest Disclosure Form	98433-conflict-of-interest-statement.pdf
Copyright License Agreement	98433-copyright-assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	98433-foundation-statement.pdf
Signed Consent for Treatment Form(s) or Document(s)	98433-informed-consent-statement.pdf
Non-Native Speakers of English Editing Certificate	98433-non-native-speakers.pdf
Peer-review Report	98433-peer-reviews.pdf
Scientific Misconduct Check	98433-scientific-misconduct-check.png
Scientific Editor Work List	98433-scientific-editor-work-list.pdf
CrossCheck Report	98433-crosscheck-report.png
CrossCheck Report	98433-crosscheck-report.pdf